FULGENT GENETICS, INC. Net Income (Loss) Attributable to Noncontrolling Interest
FULGENT GENETICS, INC. (FLGT) reported Net Income (Loss) Attributable to Noncontrolling Interest of -$189.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2026-07-30
- FULGENT GENETICS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-06-30 was -$189.00K.
- FULGENT GENETICS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-03-31 was -$448.00K.
- FULGENT GENETICS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-12-31 was -$232.00K.
- FULGENT GENETICS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-09-30 was -$218.00K.
- FULGENT GENETICS, INC. net income (loss) attributable to noncontrolling interest for fiscal 2025 was -$1.12M.
- FULGENT GENETICS, INC. net income (loss) attributable to noncontrolling interest for fiscal 2024 was -$1.11M.
- FULGENT GENETICS, INC. net income (loss) attributable to noncontrolling interest for fiscal 2023 was -$7.41M.
- FULGENT GENETICS, INC. net income (loss) attributable to noncontrolling interest for fiscal 2022 was -$1.48M.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$189.00K 10-Q · filed 2026-07-30 | -$637.00K 10-Q · filed 2026-07-30 | -$869.00K derived: sum of 3 quarters · filed 2026-07-30 | -$1.09M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | -$448.00K 10-Q · filed 2026-05-01 | -$680.00K derived: sum of 2 quarters · filed 2026-05-01 | -$898.00K derived: sum of 3 quarters · filed 2026-05-01 | -$1.20M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | -$232.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$450.00K derived: sum of 2 quarters · filed 2026-02-27 | -$749.00K derived: sum of 3 quarters · filed 2026-07-30 | -$1.12M 10-K · filed 2026-02-27 |
| 2025-09-30 | -$218.00K 10-Q · filed 2025-11-07 | -$517.00K derived: sum of 2 quarters · filed 2026-07-30 | -$886.00K 10-Q · filed 2025-11-07 | -$1.19M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | -$299.00K 10-Q · filed 2026-07-30 | -$668.00K 10-Q · filed 2026-07-30 | -$970.00K derived: sum of 3 quarters · filed 2026-07-30 | -$1.02M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | -$369.00K 10-Q · filed 2026-05-01 | -$671.00K derived: sum of 2 quarters · filed 2026-05-01 | -$717.00K derived: sum of 3 quarters · filed 2026-05-01 | -$1.10M derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | -$302.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$348.00K derived: sum of 2 quarters · filed 2026-02-27 | -$728.00K derived: sum of 3 quarters · filed 2026-02-27 | -$1.11M 10-K · filed 2026-02-27 |
| 2024-09-30 | -$46.00K 10-Q · filed 2025-11-07 | -$426.00K derived: sum of 2 quarters · filed 2025-11-07 | -$810.00K 10-Q · filed 2025-11-07 | -$7.00M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | -$380.00K 10-Q · filed 2025-08-01 | -$764.00K 10-Q · filed 2025-08-01 | -$6.95M derived: sum of 3 quarters · filed 2026-02-27 | -$7.31M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | -$384.00K 10-Q · filed 2025-05-02 | -$6.57M derived: sum of 2 quarters · filed 2026-02-27 | -$6.93M derived: sum of 3 quarters · filed 2026-02-27 | -$7.29M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | -$6.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$6.54M derived: sum of 2 quarters · filed 2026-02-27 | -$6.91M derived: sum of 3 quarters · filed 2026-02-27 | -$7.41M 10-K · filed 2026-02-27 |
| 2023-09-30 | -$359.00K 10-Q · filed 2024-11-08 | -$720.00K derived: sum of 2 quarters · filed 2024-11-08 | -$1.23M 10-Q · filed 2024-11-08 | -$1.47M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | -$361.00K 10-Q · filed 2024-08-02 | -$870.00K 10-Q · filed 2024-08-02 | -$1.11M derived: sum of 3 quarters · filed 2024-08-02 | -$1.49M derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | -$509.00K 10-Q · filed 2024-05-03 | -$753.00K derived: sum of 2 quarters · filed 2024-05-03 | -$1.13M derived: sum of 3 quarters · filed 2024-05-03 | -$1.57M derived: sum of 4 quarters · filed 2024-05-03 |
| 2022-12-31 | -$244.00K 10-K · filed 2023-02-28 | -$620.00K derived: sum of 2 quarters · filed 2023-11-03 | -$1.06M derived: sum of 3 quarters · filed 2023-11-03 | -$1.48M 10-K · filed 2025-02-28 |
| 2022-09-30 | -$376.00K 10-Q · filed 2023-11-03 | -$814.00K derived: sum of 2 quarters · filed 2023-11-03 | -$1.24M 10-Q · filed 2023-11-03 | -$1.90M derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | -$438.00K 10-Q · filed 2023-08-04 | -$860.00K 10-Q · filed 2023-08-04 | -$1.52M derived: sum of 3 quarters · filed 2023-08-04 | -$1.82M derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | -$422.00K 10-Q · filed 2023-05-05 | -$1.08M derived: sum of 2 quarters · filed 2023-05-05 | -$1.38M derived: sum of 3 quarters · filed 2023-05-05 | -$1.55M derived: sum of 4 quarters · filed 2023-05-05 |
| 2021-12-31 | -$662.00K 10-K · filed 2023-02-28 | -$960.00K derived: sum of 2 quarters · filed 2023-02-28 | -$1.13M derived: sum of 3 quarters · filed 2023-02-28 | -$1.13M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$298.00K 10-K · filed 2023-02-28 | -$463.00K derived: sum of 2 quarters · filed 2023-02-28 | -$463.00K 10-Q · filed 2022-11-07 | |
| 2021-06-30 | -$165.00K 10-K · filed 2023-02-28 | -$165.00K 10-Q · filed 2022-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |